+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Anal Cancer Market by Offering (Drugs, Therapy), Cancer Type (Adenocarcinoma, Melanoma, Squamous Cell Carcinoma), End-User - Forecast 2024-2030- Product Image
Global Anal Cancer Market by Offering (Drugs, Therapy), Cancer Type (Adenocarcinoma, Melanoma, Squamous Cell Carcinoma), End-User - Forecast 2024-2030- Product Image
Sale

Global Anal Cancer Market by Offering (Drugs, Therapy), Cancer Type (Adenocarcinoma, Melanoma, Squamous Cell Carcinoma), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967579
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anal Cancer Market size was estimated at USD 1.00 billion in 2023, USD 1.06 billion in 2024, and is expected to grow at a CAGR of 6.38% to reach USD 1.54 billion by 2030.

Anal cancer is a type of cancer that develops in the tissues of the anal canal, the final segment of the gastrointestinal tract through which stool exits the body. It is a relatively rare disease compared to other types of cancer and involves the formation of malignant cells in the area around the anus. One of the most significant risk factors for anal cancer is infection with Human Papillomavirus (HPV), particularly certain strains that are also linked to other types of cancers, and the growing incidences of HPV infections across the world create a need for anal cancer diagnostics and therapeutic interventions.

Global initiatives and efforts by the government to raise awareness about anal cancer and its symptoms also create a favorable environment for the progress of anal cancer solutions. However, precise diagnosis of anal cancer can be challenging as symptoms often resemble less severe conditions such as hemorrhoids or minor anal fissures, and the lack of standard screening protocol for anal cancer affects early detection rates. Current treatments can have severe side effects affecting the quality of life and overall health of the patient. Exploring immunotherapy treatments could offer new ways to combat anal cancer more effectively while reducing the side effects associated with traditional anal cancer treatments. Enhancing public education and awareness about the signs, risk factors, and prevention of anal cancer could lead to earlier cancer detection and better treatment outcomes.

Regional Insights

In the Americas region, particularly the U.S. and Canada, there is a significant focus on the research and development of cancer treatments, including those for anal cancer. The high prevalence of HPV, a major risk factor for anal cancer, drives a need for effective screening and treatment options. Consumers in the Americas region often have access to advanced healthcare services, influencing purchasing behaviors towards more innovative and comprehensive treatment options. The market is also shaped by health insurance policies and government support for cancer research. Countries within the EU are focused on enhancing cancer screening programs and treatment methodologies.

EU showcases a trend towards increasing investment in healthcare infrastructure and cancer research. This promotes early diagnosis and advanced treatment options, shaping consumer expectations towards high-quality care. APAC’s healthcare sector is rapidly evolving, with significant government investment in healthcare reform. The rising prevalence of anal cancer and increasing awareness have led to more robust health screening programs. Consumer behavior in APAC is strongly influenced by government policies, leading to increased adoption of both traditional and modern treatment options.

Market Trends by Segment

  • Offering: Ongoing advancements and regulatory support to improve the therapy options for anal cancer
  • Cancer Type: Rising cases of squamous cell carcinomas and need for quick and effective diagnostics and treatment interventions

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FDA Sanctions Nivolumab Combo for Advanced Urothelial Carcinoma

The FDA has approved a novel treatment regimen for unresectable or metastatic urothelial carcinoma, combining nivolumab with cisplatin and gemcitabine. This approval was based on compelling evidence from a clinical study where the primary endpoints were overall survival and progression-free survival. These outcomes were rigorously evaluated by a blinded independent central review, adhering to the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.

FDA Approves Temporary Import of Chinese-Made Cisplatin to Address Chemotherapy Shortage

In response to the critical shortage of chemotherapy treatments in the United States, the Food and Drug Administration (FDA) has authorized the temporary importation of cisplatin, a cancer-fighting drug manufactured by Qilu Pharmaceutical in China. This approval permits the distribution of the drug, packaged in 50-milligram vials, by Canadian pharmaceutical company Apotex. This temporary measure is aimed at mitigating the ongoing scarcity of essential chemotherapy medications across the country.

Alembic Pharma Secures USFDA Approval for Fluorouracil Injection

Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (USFDA) for its Fluorouracil injection USP, Pharmacy Bulk Vial. This generic medication is confirmed to be therapeutically equivalent to Spectrum Pharmaceuticals’ Fluorouracil Injection. The approved drug is designated for treating various types of adenocarcinomas, including colon, rectum, breast, stomach, and pancreatic cancers. This approval marks a crucial advancement in the availability of essential cancer treatments.

Key Company Profiles

The report delves into recent significant developments in the Anal Cancer Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ADVANCED MARKER DISCOVERY, S.L., Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd, Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, bioMérieux SA, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, DAIICHI SANKYO COMPANY, LIMITED., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Ipsen Pharma, Johnson & Johnson Services, Inc., Merck KGaA, Novartis AG, Pfizer Inc., Qilu Pharmaceutical Co. Ltd, Regeneron Pharmaceuticals Inc., SANOFI WINTHROP INDUSTRIE, Taj Pharmaceuticals Limited, and Teva Pharmaceutical Industries Ltd.

This research report offers invaluable insights into various crucial aspects of the Anal Cancer Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of anal cancer across the globe
5.1.1.2. Supportive government investments and initiatives for anal cancer treatments
5.1.2. Restraints
5.1.2.1. Expensive nature of drugs and therapies used to treat anal cancer
5.1.3. Opportunities
5.1.3.1. Approvals for new drugs and therapies for anal cancer treatment
5.1.3.2. Investments in research and development of novel drugs
5.1.4. Challenges
5.1.4.1. Long-term consequences of anal cancer drugs and therapies
5.2. Market Segmentation Analysis
5.2.1. Offering: Ongoing advancements and regulatory support to improve the therapy options for anal cancer
5.2.2. Cancer Type: Rising cases of squamous cell carcinomas and need for quick and effective diagnostics and treatment interventions
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Anal Cancer Market, by Offering
6.1. Introduction
6.2. Drugs
6.3. Therapy
7. Anal Cancer Market, by Cancer Type
7.1. Introduction
7.2. Adenocarcinoma
7.3. Melanoma
7.4. Squamous Cell Carcinoma
8. Anal Cancer Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Anal Cancer Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Anal Cancer Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Anal Cancer Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. FDA Sanctions Nivolumab Combo for Advanced Urothelial Carcinoma
12.3.2. FDA Approves Temporary Import of Chinese-Made Cisplatin to Address Chemotherapy Shortage
12.3.3. Alembic Pharma Secures USFDA Approval for Fluorouracil Injection
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. ANAL CANCER MARKET RESEARCH PROCESS
FIGURE 2. ANAL CANCER MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANAL CANCER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANAL CANCER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ANAL CANCER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANAL CANCER MARKET DYNAMICS
FIGURE 7. GLOBAL ANAL CANCER MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ANAL CANCER MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANAL CANCER MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ANAL CANCER MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ANAL CANCER MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. ANAL CANCER MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ANAL CANCER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANAL CANCER MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ANAL CANCER MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ANAL CANCER MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ANAL CANCER MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ANAL CANCER MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ANAL CANCER MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ANAL CANCER MARKET SIZE, BY CARBOPLATIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ANAL CANCER MARKET SIZE, BY CARBOPLATIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ANAL CANCER MARKET SIZE, BY CISPLATIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ANAL CANCER MARKET SIZE, BY CISPLATIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ANAL CANCER MARKET SIZE, BY FLUOROURACIL, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ANAL CANCER MARKET SIZE, BY FLUOROURACIL, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ANAL CANCER MARKET SIZE, BY LEUCOVORIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ANAL CANCER MARKET SIZE, BY LEUCOVORIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ANAL CANCER MARKET SIZE, BY MITOMYCIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ANAL CANCER MARKET SIZE, BY MITOMYCIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ANAL CANCER MARKET SIZE, BY OXALIPLATIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ANAL CANCER MARKET SIZE, BY OXALIPLATIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ANAL CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ANAL CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ANAL CANCER MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ANAL CANCER MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ANAL CANCER MARKET SIZE, BY MELANOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ANAL CANCER MARKET SIZE, BY MELANOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ANAL CANCER MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ANAL CANCER MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ANAL CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ANAL CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL ANAL CANCER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL ANAL CANCER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. CANADA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 84. CANADA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 85. CANADA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 86. CANADA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 87. CANADA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 88. CANADA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 89. CANADA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 90. CANADA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 91. CANADA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. CANADA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. MEXICO ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 94. MEXICO ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 95. MEXICO ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 96. MEXICO ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 97. MEXICO ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 98. MEXICO ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 99. MEXICO ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 100. MEXICO ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 101. MEXICO ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. MEXICO ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. CHINA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 138. CHINA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 139. CHINA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 140. CHINA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 141. CHINA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 142. CHINA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 143. CHINA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 144. CHINA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 145. CHINA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. CHINA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. INDIA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 148. INDIA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 149. INDIA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 150. INDIA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 151. INDIA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 152. INDIA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 153. INDIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 154. INDIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 155. INDIA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. INDIA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. JAPAN ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 168. JAPAN ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 169. JAPAN ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 170. JAPAN ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 171. JAPAN ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 172. JAPAN ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 173. JAPAN ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 174. JAPAN ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 175. JAPAN ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. JAPAN ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. THAILAND ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 228. THAILAND ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 229. THAILAND ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 230. THAILAND ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 231. THAILAND ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 232. THAILAND ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 233. THAILAND ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 234. THAILAND ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 235. THAILAND ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. THAILAND ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 259. DENMARK ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 260. DENMARK ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 261. DENMARK ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 262. DENMARK ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 263. DENMARK ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 264. DENMARK ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 265. DENMARK ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 266. DENMARK ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 267. DENMARK ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. DENMARK ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. EGYPT ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 270. EGYPT ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 271. EGYPT ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 272. EGYPT ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 273. EGYPT ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 274. EGYPT ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 275. EGYPT ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 276. EGYPT ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 277. EGYPT ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. EGYPT ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. FINLAND ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 280. FINLAND ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 281. FINLAND ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 282. FINLAND ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 283. FINLAND ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 284. FINLAND ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 285. FINLAND ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 286. FINLAND ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 287. FINLAND ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. FINLAND ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. FRANCE ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 290. FRANCE ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 291. FRANCE ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 292. FRANCE ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 293. FRANCE ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 294. FRANCE ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 295. FRANCE ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 296. FRANCE ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 297. FRANCE ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. FRANCE ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. GERMANY ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 300. GERMANY ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 301. GERMANY ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 302. GERMANY ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 303. GERMANY ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 304. GERMANY ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 305. GERMANY ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 306. GERMANY ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 307. GERMANY ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. GERMANY ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 319. ITALY ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 320. ITALY ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 321. ITALY ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 322. ITALY ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 323. ITALY ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 324. ITALY ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 325. ITALY ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 326. ITALY ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 327. ITALY ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 328. ITALY ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 337. NETHERLANDS ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. NETHERLANDS ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 340. NIGERIA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 341. NIGERIA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 342. NIGERIA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 343. NIGERIA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 344. NIGERIA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 345. NIGERIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 346. NIGERIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 347. NIGERIA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 348. NIGERIA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 349. NORWAY ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 350. NORWAY ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 351. NORWAY ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 352. NORWAY ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 353. NORWAY ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 354. NORWAY ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 355. NORWAY ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 356. NORWAY ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 357. NORWAY ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 358. NORWAY ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 359. POLAND ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 360. POLAND ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 361. POLAND ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 362. POLAND ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 363. POLAND ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 364. POLAND ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 365. POLAND ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 366. POLAND ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 367. POLAND ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 368. POLAND ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 369. QATAR ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 370. QATAR ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 371. QATAR ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 372. QATAR ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 373. QATAR ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 374. QATAR ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 375. QATAR ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 376. QATAR ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 377. QATAR ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 378. QATAR ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 379. RUSSIA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 380. RUSSIA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 381. RUSSIA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 382. RUSSIA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 383. RUSSIA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 384. RUSSIA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 385. RUSSIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 386. RUSSIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 387. RUSSIA ANAL CANCER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 388. RUSSIA ANAL CANCER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 389. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
TABLE 390. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
TABLE 391. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 392. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 393. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY THERAPY, 2018-2023 (USD MILLION)
TABLE 394. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY THERAPY, 2024-2030 (USD MILLION)
TABLE 395. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 396. SAUDI ARABIA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 397. SAUDI ARABIA AN

Companies Mentioned

  • AbbVie Inc.
  • ADVANCED MARKER DISCOVERY, S.L.
  • Alembic Pharmaceuticals Limited
  • Alembic Pharmaceuticals Ltd
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • bioMérieux SA
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • DAIICHI SANKYO COMPANY, LIMITED.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Ipsen Pharma
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Qilu Pharmaceutical Co. Ltd
  • Regeneron Pharmaceuticals Inc.
  • SANOFI WINTHROP INDUSTRIE
  • Taj Pharmaceuticals Limited
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.06 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.54 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Anal Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Anal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 164 Pages
  • Global
From
Anal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Anal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 133 Pages
  • Global
From
Anal and Colorectal Cancer Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Anal and Colorectal Cancer Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 104 Pages
  • Global
From
Anal Cancer - Pipeline Insight, 2024 - Product Image

Anal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
5-fluorouracil Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

5-fluorouracil Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 78 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.